Document is current
Any future updates will be listed below
-
Authors
Lazar Neto, Felippe http://orcid.org/0000-0002-0051-9537
Mercadé-Besora, Núria
Raventós, Berta
Pérez-Crespo, Laura
Castro Junior, Gilberto http://orcid.org/0000-0001-8765-3044
Ranzani, Otavio T. http://orcid.org/0000-0002-4677-6862
Duarte-Salles, Talita http://orcid.org/0000-0002-8274-0357
- License Information
-
More Information
Article History
Received: 2 November 2023
Accepted: 28 May 2024
First Online: 19 June 2024
Competing interests
: GCJ reports outside the scope of this paper to have received honorariums from AstraZeneca, Pfizer, Merck, Bristol-Myers, Novartis, Roche, Amgem, Janssen, Lilly, Takeda, Daiichi Sankyo, in addition to playing advisory roles to Boehringer, Pfizer, Bayer, Roche, Merck, Bristol-Meyers, AstraZeneca, Yuhan, Janssen, Libbs, Sanofi, Novartis, Lilly, Takeda, and Daiichi Sankyo. The remaining authors have no conflicts of interest to disclose.
